Identifying disease-causing variants in proteins that span cell membranes
A pipeline for identifying disease-causing variants in transmembrane proteins
This study is looking for specific genetic changes that can lead to diseases by examining important proteins in our bodies, and it’s designed to help improve how we diagnose and treat people with genetic conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10789901 on NIH RePORTER |
What this research studies
This research aims to discover genetic variants that cause diseases by focusing on transmembrane proteins, which are crucial for many bodily functions. The approach involves analyzing genetic data from a large biobank to identify associations between specific genetic variants and diseases. Researchers will use a scoring system to evaluate how these variants affect health and will conduct laboratory tests to understand their functions better. This work could lead to improved diagnosis and treatment options for patients with genetic conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with rare genetic variants linked to Mendelian diseases, particularly those involving transmembrane proteins.
Not a fit: Patients with common diseases not associated with genetic variants in transmembrane proteins may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate identification of genetic causes of diseases, enabling better-targeted treatments for patients.
How similar studies have performed: Other research has successfully identified disease-causing variants using similar genetic analysis methods, indicating a promising approach.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Glazer, Andrew M. — Vanderbilt University Medical Center
- Study coordinator: Glazer, Andrew M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.